DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ advanced 2.68% to $44.14 Wednesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 1.40% to 16,742.39 and the Dow Jones Industrial Average rising 0.88% to 39,908.00.
This was the stock's second consecutive day of gains.
Corbus Pharmaceuticals Holdings Inc. closed $5.73 short of its 52-week high ($49.87), which the company achieved on March 13th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Vanda Pharmaceuticals Inc. $(VNDA)$ rose 4.48% to $5.36, Fortress Biotech Inc. (FBIO) fell 1.14% to $1.74, and Viking Therapeutics Inc. $(VKTX)$ rose 7.60% to $78.01.
Trading volume (251,845) remained 31,185 below its 50-day average volume of 283,030.
Data source: Dow Jones Market Data, FactSet. Data compiled May 15, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 15, 2024 17:28 ET (21:28 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments